Immune system development and function in prolactin receptor-deficient mice

Citation
B. Bouchard et al., Immune system development and function in prolactin receptor-deficient mice, J IMMUNOL, 163(2), 1999, pp. 576-582
Citations number
43
Categorie Soggetti
Immunology
Journal title
JOURNAL OF IMMUNOLOGY
ISSN journal
00221767 → ACNP
Volume
163
Issue
2
Year of publication
1999
Pages
576 - 582
Database
ISI
SICI code
0022-1767(19990715)163:2<576:ISDAFI>2.0.ZU;2-A
Abstract
Prolactin (PRL) is the primary lactogenic pituitary hormone that plays an e ssential role in many aspects of reproduction, from fertilization to mammar y gland development and maternal behavior. PRL has also been reported to pl ay a role in immunoregulation, Because initial observations indicated that hypophysectomized rats present abnormalities of the immune system, includin g increased thymic atrophy and lymphopenia, a number of studies have focuse d on the potential immunomodulatory roles of PRL, This hormone exerts its b iological activities following binding to specific cell surface PRL recepto rs (PRLRs), In this report, we have characterized the development and funct ion of the immune system in PRLR-deficient mice. Compared with wild-type co ntrol mice, PRLR-/- mice demonstrate no alterations in thymic or splenic ce llularity or in the composition of the lymphocyte subsets present in primar y (bone marrow and thymus) or secondary (spleen and lymph nodes) lymphoid o rgans. Lymphocytes from PRLR-/- mice are functional in vitro, as they can p roliferate normally to mitogens, cytokines, and allogeneic cells. PRLR-/- s plenocytes display normal NK-mediated cytotoxicity to YAC-1 target cells. I n vivo studies have revealed that PRLR-/- mice are able to 1) generate norm al steady-state Ig levels, 2) mount a normal specific Ig response following immunization with a T-dependent Ag, 3) eliminate injected allogeneic tumor cells, and 3) effectively control Listeria monocytogenes infection. Taken together, these results show that immune system development and function pr oceed normally in the absence of PRL-mediated signaling and suggest that PR LR pathways are not essential for immunomodulation in vivo.